Zobrazeno 1 - 10
of 894
pro vyhledávání: '"TSUTOMU MASAKI"'
Autor:
Tomoko Tadokoro, Joji Tani, Takushi Manabe, Kei Takuma, Mai Nakahara, Kyoko Oura, Shima Mimura, Koji Fujita, Takako Nomura, Asahiro Morishita, Hideki Kobara, Takashi Himoto, Masafumi Ono, Tsutomu Masaki
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Portal vein thrombosis (PVT) worsens the long-term prognosis of patients with cirrhosis; however, the optimal treatment remains to be determined. Reports on the efficacy of direct oral anticoagulants are increasing, and further evidence is n
Externí odkaz:
https://doaj.org/article/edf0293d1b7b41aca4d8da2b8ed176f0
Autor:
Michihiro Iwaki, Hideki Fujii, Hideki Hayashi, Hidenori Toyoda, Satoshi Oeda, Hideyuki Hyogo, Miwa Kawanaka, Asahiro Morishita, Kensuke Munekage, Kazuhito Kawata, Tsubasa Tsutsumi, Koji Sawada, Tatsuji Maeshiro, Hiroshi Tobita, Yuichi Yoshida, Masafumi Naito, Asuka Araki, Shingo Arakaki, Takumi Kawaguchi, Hidenao Noritake, Masafumi Ono, Tsutomu Masaki, Satoshi Yasuda, Eiichi Tomita, Masato Yoneda, Akihiro Tokushige, Yoshihiro Kamada, Hirokazu Takahashi, Shinichiro Ueda, Shinichi Aishima, Yoshio Sumida, Atsushi Nakajima, Takeshi Okanoue
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 2, Pp 225-234 (2024)
Background/Aims Metabolic dysfunction-associated steatotic liver disease (MASLD) was recently proposed as an alternative disease concept to nonalcoholic fatty liver disease (NAFLD). We aimed to investigate the prognosis of patients with biopsy-confir
Externí odkaz:
https://doaj.org/article/1c45e86853d948bb846d9cb50e10dad4
Autor:
Tomoko Tadokoro, Takako Nomura, Koji Fujita, Takushi Manabe, Kei Takuma, Mai Nakahara, Kyoko Oura, Shima Mimura, Joji Tani, Asahiro Morishita, Hideki Kobara, Masafumi Ono, Tsutomu Masaki
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Hepatocellular carcinoma (HCC) in autoimmune hepatitis (AIH) was considered rare but is increasing with prolonged prognosis. Its impact on the overall prognosis of AIH is unknown, and treatment has not been established. Aim To inv
Externí odkaz:
https://doaj.org/article/b1e1db6200a24ae49e2fc299f5bec07e
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Alcohol abuse is associated with several diseases, such as hepatocellular carcinoma, cirrhosis, and extrahepatic malignancies. Recently, we reported albumin platelet product (APP) and modified APP (mAPP) as novel indices of liver fibrosis st
Externí odkaz:
https://doaj.org/article/f8ecefc171f34a13a830096e2ec4758c
Autor:
Kyoko Oura, Asahiro Morishita, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Shima Mimura, Joji Tani, Masafumi Ono, Takashi Himoto, Tsutomu Masaki
Publikováno v:
Cancer Medicine, Vol 12, Iss 24, Pp 22023-22037 (2023)
Abstract Aim Indications of drug therapies to elderly patients with hepatocellular carcinoma (HCC) should be carefully determined. The current study assessed the safety and efficacy of molecular targeted agents (MTAs) in the elderly patients with HCC
Externí odkaz:
https://doaj.org/article/1f9fc393f2c049ff98af5d20111cb879
Autor:
Miwa Tatsuta, Masafumi Ono, Shungo Kimura, Kaori Zuigyo, Yudai Sato, Akemi Tomida, Mitsuyoshi Kobayashi, Ritsuko Yoshikawa, Satoshi Murao, Joji Tani, Asahiro Morishita, Hideki Kobara, Takashi Himoto, Tsuyoshi Maeta, Yoshihiro Mori, Fumikazu Kohi, Tsutomu Masaki
Publikováno v:
JGH Open, Vol 7, Iss 12, Pp 990-997 (2023)
Abstract Background and Aim Nonalcoholic fatty liver disease (NAFLD) is closely associated with metabolic syndrome. This study was performed to examine the association between NAFLD and each factor of metabolic syndrome and to identify the factors th
Externí odkaz:
https://doaj.org/article/70a00d6c9eb14da892fb7be30fc611bb
Publikováno v:
Microorganisms, Vol 12, Iss 9, p 1926 (2024)
Chronic hepatitis C virus (HCV) infection is associated with an increased risk of extrahepatic cancers, particularly non-Hodgkin lymphoma. The introduction of direct-acting antivirals (DAAs) has revolutionized HCV therapy, resulting in high cure rate
Externí odkaz:
https://doaj.org/article/0032883a2bf04a9e9f66bece70907b2d
Autor:
Yudai Sato, Tomoko Tadokoro, Hiroki Yamana, Hiraki Akai, Kei Takuma, Naoki Fujita, Mai Nakahara, Kyoko Oura, Koji Fujita, Joji Tani, Hideki Kamada, Asahiro Morishita, Hideki Kobara, Seiko Kagawa, Reiji Haba, Keiichi Okano, Tsutomu Masaki
Publikováno v:
DEN Open, Vol 4, Iss 1, Pp n/a-n/a (2024)
Abstract Hepatocellular carcinoma invasion of the bile duct is rare and has a poor prognosis. A 77‐year‐old man presented at the emergency department with persistent pain in the right hypochondrium. Blood tests and imaging studies revealed a 70
Externí odkaz:
https://doaj.org/article/fc380b8c52934850ae901bdfcd046599
Autor:
Yasuhiro Hamada, Tadayuki Takata, Hisakazu Iwama, Rie Kawakita, Wakako Nonaka, Kazushi Deguchi, Hideki Kobara, Asahiro Morishita, Osamu Miyamoto, Takehiro Nakamura, Toshifumi Itano, Tsutomu Masaki
Publikováno v:
Heliyon, Vol 10, Iss 7, Pp e28875- (2024)
Neuroprotective therapeutic potential for restoring dysregulated microRNA (miRNA) expression has previously been demonstrated in a gerbil cerebral infarction model. However, since temporal changes in miRNA expression profiles following stroke onset a
Externí odkaz:
https://doaj.org/article/aebe99b5ecc74bfc841bd2bd52d6145e
Autor:
Tetsu Tomonari, Joji Tani, Yasushi Sato, Hironori Tanaka, Takahiro Tanaka, Tatsuya Taniguchi, Morishita Asahiro, Koichi Okamoto, Masahiro Sogabe, Hiroshi Miyamoto, Naoki Muguruma, Tsutomu Masaki, Tetsuji Takayama
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 2646-2657 (2023)
Abstract Aim We analyzed the association between the modified albumin–bilirubin (mALBI) grade and therapeutic efficacy of atezolizumab plus bevacizumab (Atezo+Bev) for the treatment of unresectable hepatocellular carcinoma (u‐HCC). Methods In thi
Externí odkaz:
https://doaj.org/article/23129d724cc64b72b7ff27bc4b68d119